Safety and Efficacy of Allogeneic Cells for the Treatment of Intermittent Claudication(IC)

Cardiovascular Institute, Mount Sinai School of Medicine, New York

Turkey Creek Medical Center, Knoxville

Florida Researc Network, LLC, Gainesville

Tampa Bay Medical Research, Clearwater

DMI Research, Pinellas Park

Cardiology, P. C. and Center for Therapeutic Angiogenesis, Birmingham

Universitätsklinikum Münster, Münster

Medical College of Wisconsin, Milwaukee

Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Mainz

Cardiovascular Division, MMC, University of Minnesota, Minneapolis

Edith Wolson Medical Center, Holon

Northwestern University, Chicago

Universitätsklinik Heidelberg, Heidelberg

SRH Klinikum Karlsbad-Langensteinbach, Karlsbad

Clinical Trials of Texas, San Antonio

Universtiäts-Herzzentrum Freiburg und Bad-Krozingen, Bad Krozingen

Universitätsklinikum Jena, Jena

Dr. Nadarajah Janaki, Evans

Duke University, Durham

Dr. Mohler Emile, Philadelphia

Franziskus-Krankenhaus, Berlin

Universitätsklinikum Carl Gustav Carus, Dresden

ASKLEPIOS Klinik St. Georg, Hamburg

"Mor Instituite, Horev M.C", Haifa

University of Kentucky Research Foundation, Lexington

Omega Medical Center, Warwick

Dong-A University Hospital, Seo-gu

Korea University Ansan Hospital, Ansan

National Health Insurance Service Ilsan Hospital, Ilsandong-gu, Goyang-si

Ajou University Hospital, Suwon

Dr. Sungwon Chung, Busan

Dr. Weonyong Lee, Gyeonggi-do

Dr. Changyoung Lim, Gyeonggi-do

Kangbuk Samsung Medical Center, Seoul